KCT0001490招募中未知
Comparative study between Korea and Japan on endoscopic diagnosis and treatment of gastrointestinal diseases
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 5,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 20(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •Subjects who are diagnosed as gastrointestinal disease using endoscopic procedure at Konkuk University
- •Adults equal or above 20 years old
- •Subjects who are not contraindicated to gastrointestinal endoscopic procedure
排除标准
- •Subjects without endoscopic procedural findings
- •Uncertain condition that cannot be diagnosed by endoscopy
研究者
相似试验
尚未招募
不适用
A Japan-South Korea joint research project on intraductal papillary tumour, mucinous cystic tumour or neoplasm, and papillary bile duct carcinomaJPRN-UMIN000022933Dokkyo Medical University400
已完成
不适用
A Korea-Japan multicenter joint project on Postoperative Adjuvant treatment for Ampulla of Vater cancerAmpulla of Vater CancerJPRN-UMIN000037916Japanese Society of Hepato-Biliary-Pancreatic Surgery1,090
未知
1 期
A Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Patients With Castration-Resistant Prostate CancerChemotherapy-naive castration-resistant prostate cancerJPRN-jRCT2080221877Takeda Pharmaceutical Company Limited72
进行中（未招募）
1 期
Study to find out the effects and fate of treatment with Orteronel plus prednisone in Japanese and non Japanese people that have not recieved cancer therapy for prostate cancer.progressive castration-resistant prostate cancer.MedDRA version: 14.1Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-001539-30-NLMillennium Pharmaceuticals, Inc.144
已完成
2 期
A Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naïve Patients With Castration-Resistant Prostate Cancercastrationresistant prostate cancer (mCRPC)chemotherapy-naïvemetastaticprogressiveprostate cancer1003859310036958NL-OMON37312Millenium Pharmaceuticals8